Verdence Capital Advisors LLC Has $7.99 Million Stock Holdings in HCA Healthcare, Inc. $HCA

Key Points

• Verdence Capital Advisors LLC increased its stake in HCA Healthcare, owning 20,843 shares worth approximately $7.99 million after a 6.5% boost in the second quarter.
• HCA Healthcare reported $6.84 earnings per share for the last quarter, exceeding analysts' expectations, and had a revenue of $18.61 billion, which was above estimates as well.
• The company declared a quarterly dividend of $0.72, with an annualized dividend yield of 0.7% and a low payout ratio of 12.11%.

Verdence Capital Advisors LLC boosted its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 6.5% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 20,843 shares of the company's stock after purchasing an additional 1,274 shares during the quarter. Verdence Capital Advisors LLC's holdings in HCA Healthcare were worth $7,985,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Chung Wu Investment Group LLC acquired a new stake in HCA Healthcare in the second quarter worth $27,000. Ameriflex Group Inc. bought a new stake in HCA Healthcare in the 2nd quarter valued at about $27,000. Cheviot Value Management LLC acquired a new stake in HCA Healthcare in the first quarter valued at approximately $26,000. Saudi Central Bank acquired a new position in shares of HCA Healthcare during the first quarter worth approximately $26,000. Finally, WPG Advisers LLC acquired a new stake in HCA Healthcare in the 1st quarter valued at $27,000. Institutional investors own 62.73% of the company's stock.

Insider Buying and Selling at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 3,836 shares of the firm's stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the transaction, the executive vice president directly owned 31,503 shares in the company, valued at approximately $13,194,716.52. This trade represents a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.30% of the stock is currently owned by corporate insiders.

HCA Healthcare Price Performance

Shares of NYSE HCA opened at $414.73 on Monday. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $439.01. The business's fifty day moving average price is $405.12 and its 200-day moving average price is $376.08. The stock has a market capitalization of $97.04 billion, a PE ratio of 17.43, a P/E/G ratio of 1.31 and a beta of 1.40.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, topping analysts' consensus estimates of $6.20 by $0.64. The firm had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The company's quarterly revenue was up 6.4% on a year-over-year basis. During the same quarter last year, the business earned $5.50 earnings per share. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, equities analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th were given a $0.72 dividend. The ex-dividend date was Tuesday, September 16th. This represents a $2.88 annualized dividend and a dividend yield of 0.7%. HCA Healthcare's payout ratio is 12.11%.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on HCA shares. Wall Street Zen raised shares of HCA Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday, July 5th. Weiss Ratings restated a "buy (b-)" rating on shares of HCA Healthcare in a report on Wednesday, October 8th. Wells Fargo & Company lifted their target price on shares of HCA Healthcare from $375.00 to $412.00 and gave the stock an "equal weight" rating in a research report on Tuesday, October 7th. Wolfe Research downgraded HCA Healthcare from an "outperform" rating to a "peer perform" rating in a research report on Monday, July 28th. Finally, JPMorgan Chase & Co. upped their price objective on HCA Healthcare from $360.00 to $370.00 and gave the company a "neutral" rating in a research note on Monday, August 4th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and nine have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, HCA Healthcare has an average rating of "Moderate Buy" and a consensus target price of $422.31.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.